Member Info for Noise

The curious thing about that is that the Japanese endometriosis trial seems to be a different deal to the JV for GeneICE/101.

Btw, was that equity line at the end of the RNS strictly necessary? Very odd inclusion. But whatevs

Option for some OK movement, plus we still have some known 201 trial results waiting, so I think there is quite a lot of pumping left to be done.

I'm quite pleased to be sat at my PC with gmail and signed up to RNS announcements to my phone.

Exited a large chunk quite nicely (for once in my life).

Ignoring sales price concerns for a moment. I have liked Suzy's approach in the past and I wish her well. She is academic enough and has had experience on the Valiseek side running that business.

Have we had a company presentation in the last year? It would be nice to get a refreshed position now the difficult changes are starting to be implemented.

This was the last useful update received on Dec 2019:

"The results appear, in advance of full analysis, to indicate that the VAL201 compound has a clear impact on patients with prostate cancer, as measured by PSA - evidence that is supported from tumour imaging (MRI and CT) in subjects. The compound has also shown it is very safe and has a high degree of tolerability, up to a dose that is in excess of the predicted dose and any practical therapeutic concentration. "

Creeping up to 23p now. Would prefer a longer term revaluation, so I will not call BOOMTOWN yet.

Roses isn't paid to comment on 101 so he'll leave that topic alone.

The F

I have seen the rumour. That is a bit random and weirdly timed.

Interesting..... someone wanting to develop VAL101 etc.?

Hi Chelsea, how are things going?

Who would have thought, VAL and Scancell going boomtown in the same couple of days. Good news for both sets of investors.

In your opinion, does this "Scancell does COVID19" thing have any real legs? Or is just investor clickbait? Bit early to tell with the science on that one.

Decent movement but at current mcap isn't anything too exciting.

We are now nearly 5 months post-trial, it would be nice to see the flipping data we were promised.

Hm, probably nothing in the grand scheme of things, but a bit of a spike there, on small volume or bigger?

Yeah... well christ I can see what they were trying to do (again), but they could have just sodding announced the 201 results in an RNS before going out in this manner.

Christ, by some margin too.

Is that 98% of the yes/no's going against her? That is quite an ironic number in hindsight (share price drop over time).

Satu is gone too. Resolution passed

Dispirited I suppose.

The weekly Eastenders-esque plot lines on this share are tiring.

For whatever reason, the price is up today.

Strange. Oh well. Perhaps it really is the start of a new era...

Possibly. But realistically, wth does it say about our 201/301 trials kicking off the main director in charge of it?

I suppose it is less problematic than at Phase 1.

I suppose what I'm asking is, what is the path forward now?

Well, you have your wish

George has resigned.

Hope you are happy fella. I am slightly miffed to see him leave, but then I am not 100% clear to the history between your fallout.

There will be plenty of interest in lithium batteries, probably paired with green hydrogen storage in Europe. Some rather startling figures coming out for offshore wind-to-hydrogen artificial islands in the North Sea recently.

If Europe can get the Serbian Jadar and Cinovec projects up and running, plus the 10GW "NortH2" project, the world may become greener than we think by 2030.

Honestly Drac, I had a mild heart failure when I saw the share price, I thought George had dropped some 201 trial data or something, but I presume this is the new consolidation taking place?